photo
Speaker

Selina Koch, PHD

EXECUTIVE EDITOR, BIOCENTURY INC.
San Carlos, California, United States
Selina directs and edits the long-form analytical articles and infographics at BioCentury, covering scientific, corporate and strategic content across the biomedical ecosystem. Selina has domain expertise across a wide range of topics relevant to drug developers. Her first love is neurology. She has a deep understanding of neurodegenerative disorders, particularly Alzheimer’s disease, as well as conditions affecting ion channels.

Selina joined BioCentury in 2014 after earning a Ph.D. in Neuroscience and conducting postdoctoral research at the University of California San Francisco. Her experiments investigated the role of synaptic plasticity in shaping the development of brain circuits. She holds a B.S. in Neurobiology and Behavior from the University of Washington.
Speaking In
1:00 PM - 2:00 PM (PDT)
Tuesday, October 13
As the furthest developed new Alzheimer’s therapy candidate approaches a regulatory review decision…